The CXCL12-CXCR4 axis can recruit immune cells such as T cells and dendritic cells to TME, thereby enhancing immune surveillance and influencing tumor progression through immune-mediated pathways, consistent with the results of TIIC analysis in this study (28–31). The gene discussed is CXCR4; the disease is neoplasm.